GRP
CRSP icon

Global Retirement Partners’s CRISPR Therapeutics CRSP Stock Holding History

Global Retirement Partners’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$81K Buy
1,545
+567
+58% +$34K ﹤0.01% 2040
2025
Q3 		$63.4K Hold
978
– – ﹤0.01% 1771
2025
Q2 		$47.6K Buy
+978
New +$37.8K ﹤0.01% 1800
2024
Q4 		$38.7K Sell
984
-1,291
-57% -$61K ﹤0.01% 1749
2024
Q3 		$107K Hold
2,275
– – ﹤0.01% 1207
2024
Q2 		$123K Hold
2,275
– – ﹤0.01% 1093
2024
Q1 		$155K Hold
2,275
– – 0.01% 892
2023
Q4 		$144K Buy
2,275
+725
+47% +$40.1K 0.01% 884
2023
Q3 		$64.5K Hold
1,550
– – ﹤0.01% 1141
2023
Q2 		$87K Hold
1,550
– – ﹤0.01% 1007
2023
Q1 		$76.2K Buy
1,550
+1,500
+3,000% +$72.9K ﹤0.01% 1037
2022
Q4 		$2.03K Hold
50
– – ﹤0.01% 2359
2022
Q3 		$3K Hold
50
– – ﹤0.01% 2078
2022
Q2 		$3K Hold
50
– – ﹤0.01% 2036
2022
Q1 		$3K Sell
50
-107
-68% -$6.72K ﹤0.01% 2035
2021
Q4 		$12K Sell
157
-250
-61% -$21.8K 0.01% 143
2021
Q3 		$46K Sell
407
-100
-20% -$12.6K ﹤0.01% 884
2021
Q2 		$82K Hold
507
– – 0.01% 688
2021
Q1 		$62K Buy
507
+354
+231% +$53.5K 0.01% 705
2020
Q4 		$23K Buy
+153
New +$18.1K ﹤0.01% 982

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GP
GSK plc London $599M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Global Retirement Partners's CRSP Position: Q4 2025 in Review

Global Retirement Partners increased its CRISPR Therapeutics (CRSP) stake by 58% in Q4 2025, buying an estimated $34K and bringing the position to 1,545 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #2040.

Global Retirement Partners first reported a position in CRSP in Q4 2020 and has held it in 20 quarters since. The position peaked at $155K in Q1 2024. 479 funds tracked by Wall St. Rank hold CRSP as of Q4 2025.

  • Global Retirement Partners held 1,545 shares of CRISPR Therapeutics worth $81K as of Q4 2025.
  • Global Retirement Partners bought 567 CRISPR Therapeutics shares in Q4 2025, an estimated $34K.
  • CRISPR Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2040 holding.
  • Global Retirement Partners first reported a position in CRISPR Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • Global Retirement Partners's CRISPR Therapeutics position peaked at $155K in Q1 2024.
  • 479 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.